Moderna Inc (MRNA)
41.11
+2.86
(+7.48%)
USD |
NASDAQ |
Nov 22, 16:00
41.35
+0.24
(+0.58%)
After-Hours: 20:00
Moderna Revenue (TTM): 5.056B for Sept. 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 5.056B |
| June 30, 2024 | 4.988B |
| March 31, 2024 | 5.083B |
| December 31, 2023 | 6.754B |
| September 30, 2023 | 9.09B |
| June 30, 2023 | 10.52B |
| March 31, 2023 | 14.77B |
| December 31, 2022 | 18.88B |
| September 30, 2022 | 20.68B |
| June 30, 2022 | 22.28B |
| March 31, 2022 | 21.93B |
| December 31, 2021 | 17.74B |
| September 30, 2021 | 11.02B |
| Date | Value |
|---|---|
| June 30, 2021 | 6.199B |
| March 31, 2021 | 2.013B |
| December 31, 2020 | 274.00M |
| September 30, 2020 | 55.52M |
| June 30, 2020 | 56.86M |
| March 31, 2020 | 37.88M |
| December 31, 2019 | 48.00M |
| September 30, 2019 | 70.30M |
| June 30, 2019 | 93.62M |
| March 31, 2019 | 109.42M |
| December 31, 2018 | 122.77M |
| September 30, 2018 | 178.37M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
37.88M
Minimum
Mar 2020
22.28B
Maximum
Jun 2022
8.874B
Average
6.476B
Median
Revenue (TTM) Benchmarks
| Eli Lilly and Co | 40.86B |
| Merck & Co Inc | 63.17B |
| Pfizer Inc | 59.37B |
| Novavax Inc | 847.25M |
| Biogen Inc | 9.608B |